Home>Topics>Companies>Medtronic

Medtronic MDT

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. ETF Reports
  7. Headlines
    1. Boston Scientific Exceeds Our Expectations in the Second Quarter

      Commentary

      Thu, 24 Jul 2014

      racked up 4% year-over-year ICD growth--the strongest seen in 12 quarters. Although peers St. Jude Medical and Medtronic have both launched leadless pacemakers, Boston still offers the only leadless ICD. While Boston's monopoly position

    2. Medtronic Not Sticking Around To Rearrange Chairs On The Titanic

      Headlines

      Mon, 14 Jul 2014

      for UK-based AstraZeneca (NYSE: AZN ), and now Medtronic 's (NYSE: MDT ) acquisition of Ireland-based Covidien (NYSE ..... reduce taxes), but Dividend Growth portfolio holding Medtronic is the latest to pursue such a strategy. The medical

    3. New chief at CryoLife

      Headlines

      Fri, 11 Jul 2014

      Anderson who will transition to the role of Executive Chairman of the Board. Mr. Mackin joins the company from Medtronic ( MDT +0.5% ) where he was President of Cardiac Disease Management. Mr. Mackin's employment contract specifies a

    4. Keep Your Eyes on the Prize in M&A Deals

      Video Reports

      Thu, 10 Jul 2014

      have been paying attention to recently, [TICKER: MDT ] Medtronic agreed to acquire [TICKER:COV] Covidien, and ..... between multiple product lines, and so on. A deal like Medtronic and [TICKER:COV] Covidien probably makes a lot

      Medtronic found at 0:48, 1:26

      themselves. The two big deals that people have been paying attention to recently, [TICKER: MDT ] Medtronic agreed to acquire [TICKER:COV] Covidien, and [TICKER:ABBV] AbbVie made an offer for [TICKER:SHPG] Shire. In both cases, there's the same theme: These companies want to
      share salesforces between multiple product lines, and so on. A deal like Medtronic and [TICKER:COV] Covidien probably makes a lot more sense on that front. They're dealing with a similar customer base and have very complementary
    5. Johnson & Johnson's Artificial Pancreas May Be Launched Earlier Than Expected

      Headlines

      Wed, 9 Jul 2014

      the company is into the later stages of developing a functioning APS. Meanwhile, J&J's number one competitor, Medtronic ( MDT ) is claiming that it has won the race to get an APS to the US market with getting approval of its MiniMed 530G system

    6. New Morningstar Analyst Report for St Jude Medical Inc

      Stock Reports

      Mon, 7 Jul 2014

      Jude remains a distant second to Medtronic in the implantable cardioverter ..... wake of disappointing results from Medtronic 's controlled trial for renal denervation ..... 2014 time frame. Even though rival Medtronic eked out some pacemaker share gains

    7. iPad Used As Medical Device, Huge Success For Apple In Healthcare

      Headlines

      Sat, 5 Jul 2014

      Research : The use of Apple's ( AAPL ) iPads in the medical world is nothing new. For example, medical device maker Medtronic ( MDT ) widely uses iPads for delivering its technologies to physicians and patients worldwide. The company has developed

    8. Health Care Sector Spurred by Population Growth, M&As

      Headlines

      Tue, 1 Jul 2014

      companies seem to have the same idea. Minneapolis-based Medtronic , manufacturer of medical devices such as pacemakers, is planning ..... in Holmes Macro Trends Fund), Grifols (0.00%), Medtronic (0.00%), Covidien (0.00%), Pfizer (0.89

    9. Micro Cap Sunshine Heart Faces Medical Device Industry Challenges, Hires Boston Scientific And Medtronic Superstars

      Headlines

      Mon, 30 Jun 2014

      Senior Vice President of Clinical Affairs . Ms. Oleson was formerly vice President of Global Clinical Operations at Medtronic ( MDT ). With a market cap of around $90M, only one device in multiple stages of development, and no history of revenues

    10. Tides Turn for These Orthopedic Firms

      Headlines

      Mon, 30 Jun 2014

      an investment viewpoint. With switching costs lower in cardiac rhythm management devices, the three CRM makers-- Medtronic , St. Jude Medical, and Boston Scientific--derive much of their moatiness from efficient scale and operate in a

    « Prev12345Next »
    Content Partners